Aerin Medical specializes in providing effective, non-invasive treatments for nasal airway obstruction and chronic rhinitis. Their solutions, VivAer and RhinAer, offer significant relief and are designed to be performed safely in a doctor's office. VivAer targets nasal airway obstruction, while RhinAer addresses chronic rhinitis, both offering lasting results and minimal downtime for patients.
We're tracking Aerin Medical's market expansion
How Aerin Medical's international expansion compares to its competitors
Aerin MedicalYouBars show relative size across the companies compared.
5 metrics| Company | Markets | New markets | Momentum | Activity | Expansion score |
|---|---|---|---|---|---|
 Aerin MedicalYou | 0 | 0 | — | 0 | 0 |
Not hiring right now
Sign up to track this company and get alerted the moment something changes.
37 technologies detected across the stack.
No active campaigns
Sign up to track this company and get alerted the moment something changes.
No media coverage in this window.
Aerin Medical raised $32.5M from investors to expand operations and development of ENT treatments using proprietary temperature-controlled technology.
Unlock verified emails & direct dials
Free · No credit card needed
Quick answers about Aerin Medical's business, markets, and growth signals.
“We reach accounts the week they land in-market — not the quarter after.”
Book a walkthrough of the movement map with our team.
Pubrio turns expansion signals across 200+ markets into one live graph, so revenue teams see which companies are entering new markets, and act on the timing.
© 2026 Pubrio. All rights reserved.
